This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Biocon Limited. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: The Innovative Contributions of Rodger Liddle
Introduction
Rodger Liddle, an accomplished inventor based in Durham, NC, has made significant strides in the field of medical innovation. With a focus on disorders involving inflammation of the intestinal system, Liddle has dedicated his career to advancing potential treatments that could improve the quality of life for those suffering from these conditions.
Latest Patents
Liddle holds a notable patent for "Methods and compositions employing 4-aminophenylacetic acid compounds." This patent presents novel compositions that incorporate 4-APAA compounds, outlining methods for treating inflammatory bowel disease and other related ailments. Additionally, the innovation includes combinations of 4-APAA and 5-ASA compounds for enhanced therapeutic efficacy.
Career Highlights
In his professional journey, Rodger Liddle has aligned himself with Biocon Limited, a leading biopharmaceutical company, where he continues to focus on the development of innovative solutions in healthcare. His contributions have been vital in furthering the company’s mission to address complex medical challenges through scientific research and discovery.
Collaborations
Rodger collaborates closely with Nnochiri Ekwuribe, leveraging their combined expertise to enhance the impact of their research and contribute to the advancement of medical treatments. Their teamwork exemplifies the collaborative nature of scientific innovation, proving essential in the pursuit of breakthroughs in the treatment of intestinal disorders.
Conclusion
Rodger Liddle's innovative work not only reflects his dedication as an inventor but also has the potential to significantly improve patient outcomes in gastrointestinal health. As more discoveries emerge from his research, the impact of his inventions will undoubtedly resonate within the medical community and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
